India’s first Ayurvedic anti-diabetic drug
Q. Scientists at CSIR were awarded on 28th Sept 2016 for developing which Ayurvedic anti-diabetic drug?- Published on 28 Sep 16a. BGR-33
b. BGR-34
c. BGR-35
d. BGR-36
ANSWER: BGR-34
Scientists at the Centre for Scientific and Industrial Research were awarded for developing BGR-34, an Ayurvedic anti-diabetic drug
Senior principal scientists at CSIR said the drug has been found successful in controlling blood pressure.
- Developed around after 4 years of research at CSIR labs in Lucknow, drug was found to reduce a type of haemoglobin reflecting how well the body controls diabetes; this is called HbA1c
- Its levels reflect how well the body is controlling diabetes
- Studies on levels from 7.8 to 7.3 percent in diabetic patients given a daily dose of BGR-34 for 3 months showed that complications related to diabetes can be delayed by keeping this level below 7 percent
- Post prandial blood sugar levels reduced from 204 to 194 mg/dl
- In healthy adults, there should be less than 180 mg/dl of blood
- The drug not only controls diabetes, but also reduces the risk of co-morbidities such as hypertension and load on liver and kidney
- CSIR launched the drug late last year and it is available in pharmacies and online vendors like Amazon at the nominal cost of INR 5 per tablet
- The drug can be taken as a supplement along with allopathic medication